retatrutide pros and cons Comparing the Big 3, Semaglutide, Tirzepatide : r/Mounjaro Retatrutide and the Grey Market:

A 2021 study published in The New England Journal of Medicine found that patients taking semaglutide lost an average of 15 per cent of their body weight over 68 weeks

doi: 10.1016/S0140-6736(18)31773-2 59 AhrnBMasmiquelLKumarHSarginMKarsblJDJacobsenSHet al

Pharmacological Profile and Clinical Benefits of GLP-1 Receptor Agonists GLP-1 RAs constitute a novel class of antidiabetic medications that have reshaped the management of T2D

[DOI] [PMC free article] [PubMed] [Google Scholar] 14.Ferhatbegovic L., Mrsic D., Macic-Dzankovic A

Switching may be possible, but should only be done under the supervision of a qualified healthcare provider